157 results

• Ozempic Bowel Obstruction Caused Severe, Permanent Injuries: Lawsuit

  September 19, 2025

  Irvin Jackson

  An Ozempic lawsuit claims a Wisconsin woman suffered small bowel obstruction and gastroparesis after using the popular diabetes and weight loss drug.

• Woman Files Trulicity and Ozempic Lawsuit Over Ileus, Intestinal Obstruction

  September 5, 2025

  Irvin Jackson

  A lawsuit against the makers of Ozempic and Trulicity claims the side effects caused a woman's intestines to stop contracting, leading to a dangerous intestinal blockage.

• GLP-1 Side Effects May Increase Kidney Cancer Risks: Study

  September 3, 2025

  Irvin Jackson

  New research suggests GLP-1 drugs may lower the risk of certain cancers, but could also raise the likelihood of developing kidney cancer.

• MDL Sought for GLP-1 NAION Lawsuits Against Ozempic, Wegovy, Mounjaro Manufacturers

  August 29, 2025

  Irvin Jackson

  Eli Lilly seeks to consolidate all GLP-1 vision loss lawsuits into a new MDL, and assign them to the same court where the drugs' gastroparesis injury cases are being held.

• Gastric Emptying Study Will Be Required in Ozempic Gastroparesis Lawsuits: MDL Order

  August 20, 2025

  Irvin Jackson

  All plaintiffs filing Ozempic gastroparesis lawsuits, or gastroparesis claims involving other GLP-1 drugs, must be diagnosed through a number of court-approved gastric emptying studies.

• Lawsuit Blames Ozempic, Mounjaro, Trulicity for Gastroparesis Diagnosis

  August 15, 2025

  Irvin Jackson

  The makers of GLP-1 drugs, Novo Nordisk and Eli Lilly, face another lawsuit claiming they failed to adequately warn consumers about the risks of gastroparesis injuries.

• GLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns

  August 6, 2025

  Irvin Jackson

  New research suggests that vision problems are not restricted to just Ozempic, but may be a risk faced by all GLP-1 medication users.

• NAION Ozempic Lawsuit Filed After User’s Eye Suffers 85% Vision Loss

  July 10, 2025

  Irvin Jackson

  Novo Nordisk is facing a lawsuit alleging it failed to adequately warn about the risk of vision loss from Ozempic, including cases of NAION (non-arteritic anterior ischemic optic neuropathy).

• Ozempic Vision Risks Could Also Include Age-Related Macular Degeneration: Study

  June 23, 2025

  Irvin Jackson

  A new study links the use of Ozempic and Wegovy to an increased risk of age-related macular degeneration that could cause vision loss.

• Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court

  June 18, 2025

  Irvin Jackson

  At least 21 Ozempic and Wegovy lawsuits have been filed in New Jersey state court, involving allegations that users were left with vision loss from NAION after using the popular diabetes and weight loss drugs.